from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0249c/-

LFCtreatmentdescriptionclass of inhibitor

-0.672

Amikacinug/mL Amikacintranslation

-0.269

Cap5-10ug/mL Capreomycintranslation

-1.542

Rox10-50 ug/mL Roxithromycintranslation

1.743

SM2-5 ug/mL Streptomycintranslation

-2.379

Tet5-10 ug/mL Tetracyclinetranslation

-0.702

Rif0.2-5ug/mL Rifampicintranscription

-0.055

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.418

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.543

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.534

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.916

Clofazimine10-13 ug/mL Clofaziminerespiration

0.132

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.112

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.554

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.315

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.013

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.691

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.012

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.551

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.555

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.468

KCN5-20 ug/mL Potassium cyaniderespiration

0.506

NaN30.2-2 mM Sodium aziderespiration

0.519

Nigericin50 uM Nigericinrespiration

-1.244

TRC10-150 ug/mL Triclosanrespiration

-1.080

TRZ10-25 ug/mL Thioridazinerespiration

1.307

Valinomycin0.5-10 uM Valinomycinrespiration

0.823

ZnSO42 mM ZnSO4respiration

0.457

menadione6-10 ug/mL Menadionerespiration

-0.401

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.789

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.214

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.873

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.508

NRP_1Non-replicating persistence stage 1dosRassociated

0.752

Amp0.2mg/mL AmpicillincellWall

0.347

Cephalexin20-100 ug/mL CephalexincellWall

1.107

Cerulenin0.32-5 ug/mL CerulenincellWall

0.460

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.382

EMB10-20 ug/mL EthambutolcellWall

1.082

Eta12-40 ug/mL EthionamidecellWall

1.511

INH0.2-0.4 ug/mL IsoniazidcellWall

0.522

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.186

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.230

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.003

BZA0.12 mg/mL BenzamidearomaticAmides

0.075

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.316

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.016

H2O24 mM hydrogen peroxideDNAdamaging

-0.011

Levo10 ug/mL LevofloxacinDNAdamaging

0.560

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.944

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.107

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.508

UVUV-irradiationDNAdamaging

0.001

ARP41-4 ug/mL Antitubercular compound ARP4?

0.365

Antimycin12.5-50 ug/mL Antimycin A?

0.528

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.655

PA_110-50 ug/mL Antitubercular compound PA-1?

0.759

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.530

PA8240.2-2 ug/mL PA-824?

-0.128

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.405

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.333

Verapamil50 uM Verapamil?

0.032

mercaptoethanol2 mM 2-Mercaptoethanol?

0.206

methoxatin10-20 ug/mL Methoxatin?